| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Gunn Plastic Surgery Center is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Joimax USA is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
one45 Software Inc. is a Creston, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eos is a leading beauty and skincare brand that originated around a key insight, women want products that deliver moments of delight that transcend daily routines. From its iconic lip balm to hand and body lotion to shave cream, Eos products are hypoallergenic, dermatologist-tested, gluten-free, and packed with nourishing vitamins and natural skin-conditioning oils.